β-Cyclodextrin-dextran polymers for the solubilization of poorly soluble drugs

International Journal of Pharmaceutics

Volumn 468, Issue 1-2, 2014, Pages 258-263

  Di Cagno, Massimiliano ^a   Terndrup Nielsen, Thorbjørn ^b   Lambertsen Larsen, Kim ^b   Kuntsche, Judith ^a   Bauer Brandl, Annette ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Calorimetry (ITC); Cyclodextrins; Poorly soluble drugs; Solubilization; CD dextran polymers

Indexed keywords

BETA CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; BETA CYCLODEXTRIN DEXTRAN POLYMER; DEXTRAN; HYDROCORTISONE; IBUPROFEN; PHOSPHATE BUFFERED SALINE; POLYMER; UNCLASSIFIED DRUG; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; DELAYED RELEASE FORMULATION; DRUG CARRIER; METHYL-BETA-CYCLODEXTRIN;

ARTICLE; ASYMMETRICAL FLOW FIELD FLOW FRACTIONATION; CHEMICAL STRUCTURE; COMPLEX FORMATION; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIALYSIS; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; ENTHALPY; EQUILIBRIUM CONSTANT; FIELD FLOW FRACTIONATION; GEL PERMEATION CHROMATOGRAPHY; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR STABILITY; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; SOLUBILIZATION; THERMODYNAMICS; CALORIMETRY; CHEMISTRY; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DIFFUSION; DRUG STABILITY; GEL CHROMATOGRAPHY; KINETICS; MEDICINAL CHEMISTRY; PHARMACEUTICS; PROCEDURES; SOLUBILITY;

BETA-CYCLODEXTRINS; CALORIMETRY; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, GEL; DELAYED-ACTION PREPARATIONS; DEXTRANS; DIALYSIS; DIFFUSION; DRUG CARRIERS; DRUG STABILITY; HYDROCORTISONE; KINETICS; MOLECULAR WEIGHT; PARTICLE SIZE; SOLUBILITY; TECHNOLOGY, PHARMACEUTICAL;

EID: 84899545552     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.04.029     Document Type: Article

References (22)

1. K.A. Al-Sou'od Investigation of the hydrocortisone-β-cyclodextrin complex by phase solubility methods: some theoretical and practical consideration Journal of Solution Chemistry 37 2008 119 133
2. G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability Pharmaceutical Research 12 1995 413 420
3. M.E. Brewster, R. Vandecruys, J. Peeters, P. Neeskens, G. Verreck, and T. Loftsson Comparative interaction of 2-hydroxypropyl-β-cyclodextrin and sulfobutylether-β-cyclodextrin with itraconazole: phase solubility behavior and solubilization of supersaturated drug solution European Journal of Pharmaceutical Sciences 3 2008 103 494
4. A.K. Connors The stability of cyclodextrin complexes in solution Chemical Reviews 97 1997 1257 1325
5. M. Di Cagno, and B. Luppi Drug "supersaturation'' states induced by polymeric micelles and liposomes: a mechanistic investigation into permeability enhancements European Journal of Pharmaceutical Sciences 48 2013 775 780
6. M. Di Cagno, P.C. Stein, N. Skalko-Basnet, M. Brandl, and A. Bauer-Brandl Solubilization of ibuprofen with β-cyclodextrin derivatives: energetic and structural studies Journal of Pharmaceutical and Biomedical Analysis 55 2011 446 451
7. A. Fahr, and X. Liu Drug delivery strategies for poorly water-soluble drugs Expert Opinion on Drug Delivery 4 2007 403 416 (Pubitemid 47249138)
8. Z. Fülöp, T.T. Nielsen, K.L. Larsen, and T. Loftsson Dextran-based cyclodextrin polymers: their solubilizing effect and self-association Carbohydrate Polymers 97 2013 635 642
9. S.V. Kurkov, D.E. Madden, D. Carr, and T. Loftsson The effect of parenterally administered cyclodextrins on the pharmacokinetics of coadministered drugs Journal of Pharmaceutical Sciences 101 2012 4402 4408
10. T. Loftsson, and M.E. Brewster Pharmaceutical applications of cyclodextrins: basic science and product development Journal of Pharmacy and Pharmacology 62 2010 1607 1621
11. T. Loftsson, and M.E. Brewster Cyclodextrins as functional excipients: methods to enhance complexation efficiency Journal of Pharmaceutical Sciences 101 2012 3019 3032
12. T. Loftsson, M.E. Brewster, and M. Másson Role of cyclodextrins in improving oral drug delivery American Journal of Drug Delivery 2 2004 1 15
13. T. Loftsson, H. Frioriksdottir, A.M. Sigurdardottir, and H. Ueda The effect of water-soluble polymers on drug-cyclodextrin complexation International Journal of Pharmaceutics 110 1994 169 177 (Pubitemid 24248089)
14. T. Loftsson, A. Magnúsdóttir, A. Másson, and J.F. Sigurjónsdóttir Self-association and cyclodextrin solubilization of drugs Journal of Pharmaceutical Sciences 91 2002 2307 2316 (Pubitemid 35231194)
15. T.T. Nielsen, V. Wintgens, K.L. Larsen, and C. Amiel Synthesis and characterization of poly (ethylene glycol) based β-cyclodextrin polymers Journal of Inclusion Phenomena and Macrocyclic Chemistry 65 2009 341 348
16. T.T. Nielsen, V. Wintgens, C. Amiel, R. Wimmer, and K.L. Larsen Facile synthesis of β-cyclodextrin-dextran polymers by "click" chemistry Biomacromolecules 11 2010 1710 1715
17. A. Preiss, W. Mehnert, and K. Frömming Complexation of hydrocortisone with β-cyclodextrin and hydroxypropyl-β-cyclodextrin Archiv der Pharmazie 327 1994 729 734
18. J.R. Roberts, and S.L. Bratton Colloid volume expanders. Problems, pitfalls and possibilities Drugs 55 1998 621 630 (Pubitemid 28203771)
19. H.D. Williams, N.L. Trevaskis, S.A. Charman, S.M. Shanker, W.N. Charman, C.W. Pouton, and C.J.H. Porter Strategies to address low drug solubility in discovery and development Pharmacological Reviews 65 2013 315 499
20. J. Wong, A. Brugger, A. Khare, M. Chaubal, P. Papadopoulos, B. Rabinow, J. Kipp, and J. Ning Suspensions for intravenous(IV) injection: a review of development, preclinical and clinical aspects Advanced Drug Delivery Reviews 60 2008 939 954
21. S. Xing, Q. Zhang, C. Zhang, Q. Zhao, H. Ai, and D. Sun Isothermal titration calorimetry and theoretical studies on host-guest interaction of ibuprofen with α-, β- and γ-cyclodextrin Journal of Solution Chemistry 38 2009 531 543
22. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: therapeutic applications and developments Clinical Pharmacology and Therapeutics 83 2008 761 769 (Pubitemid 351556021)